Recent studies have confirmed that inhibiting the expression of ERBB signaling pathway or signal transduction of ERBB-related family proteins is beneficial to suppress cell migration and invasion of liver cancer [80, 81]. The gene discussed is EGFR; the disease is liver cancer.